Testing effectiveness (Phase 2)UnknownNCT05142865
What this trial is testing
Camrelizumab Combined With Chemotherapy and Apatinib for Extrapulmonary Neuroendocrine Carcinomas
Who this might be right for
Advanced or Metastatic EP-NEC
Huazhong University of Science and Technology 30